/
BCYC
$3.98-$0.08 (-1.97%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$284.2M
70M shares
52-week range
$3.75 – $9.16
4% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
ADRC
Change$-24.31
Bicycle Therapeutics plc American Depositary Shares
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.
www.bicycletherapeutics.com- Employees
- 288
- IPO / List date
- May 23, 2019
- HQ
- CAMBRIDGE, X0
Held by traders on TradeandTell
No one on the platform currently holds BCYC.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 979,300 | $4.5M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BCYC yet.
